Sell signal, week 18
Kyverna Therapeutics drops 8.7% and carves out a fresh 30-week low
Our view last week
The pause lasted one week: Kyverna Therapeutics stock sheds 4.5% and sellers take back 85% of volume, up from 57% seven days ago. Money flow turns lower again and the MACD histogram worsens for a 3rd week. The price action stays bearish, with the price pressing on its 30-day low in the 6.6 area. For swing trading, the short is up 8.8%.
This week's summary
The decline stretches after last week's relapse: Kyverna Therapeutics stock loses 8.7%, its 6th straight weekly drop, and sets a fresh 30-week low, confirmed at the close. For this healthcare stock the price action stays bearish: money flow keeps weakening and the MACD histogram falls for a 4th week. On the daily chart the RSI is below 30, in oversold territory. For swing trading, the short is up 16.7%.
IQS Phase
74
in tension
Signal Strength
32
downtrend making lower lows, pace holding
Sizing
REDUCED
Ranking
#83 / 175
US stocks
Trade P&L %
+16.73%
from signal to date, no stop loss
Kyverna Therapeutics (KYTX) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 83rd among the 175 sell signals for US stocks in our ranking, with a signal strength of 32 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
KYTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content